Burning Rock Biotech Limited
BNR
$8.83
-$0.46-4.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 03/31/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -0.35% | -0.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -0.35% | -0.35% |
| Cost of Revenue | -- | -- | -- | -13.17% | -13.17% |
| Gross Profit | -- | -- | -- | 5.89% | 5.89% |
| SG&A Expenses | -- | -- | -- | -41.00% | -41.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -35.29% | -35.29% |
| Operating Income | -- | -- | -- | 65.33% | 65.33% |
| Income Before Tax | -- | -- | -- | 60.67% | 60.67% |
| Income Tax Expenses | -- | -- | -- | 175.52% | 175.52% |
| Earnings from Continuing Operations | -- | -- | -- | 59.81% | 59.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | 59.81% | 59.81% |
| EBIT | -- | -- | -- | 65.33% | 65.33% |
| EBITDA | -- | -- | -- | 75.14% | 75.14% |
| EPS Basic | -- | -- | -- | 60.12% | 60.12% |
| Normalized Basic EPS | -- | -- | -- | 85.01% | 85.01% |
| EPS Diluted | -- | -- | -- | 60.12% | 60.12% |
| Normalized Diluted EPS | -- | -- | -- | 85.01% | 85.01% |
| Average Basic Shares Outstanding | -- | -- | -- | 1.72% | 1.72% |
| Average Diluted Shares Outstanding | -- | -- | -- | 1.72% | 1.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |